Loading

medical cannabis

  • by Paul Armentano, NORML Deputy Director May 13, 2019

    Marijuana CBD OilQualified patients now have limited access to medical cannabis products, after the state’s first licensed dispensaries began making sales this week. Voters initially approved medical cannabis access by passing a statewide initiative in November 2016.

    Under the law, qualified patients may obtain both herbal preparations of cannabis and infused cannabis products from state-licensed dispensaries. Products must be derived from plants harvested by one of five state-licensed cultivators. To date, only one cultivator is operational. Two additional cultivators are expecting to harvest their initial crops this summer.

    Nearly 12,000 patients are licensed in the state to participate in the medical cannabis access program.

    Arkansas is one of 33 states that permits medical cannabis access.

  • by Jenn Michelle Pedini, NORML Development Director February 14, 2019
    Virginia SB1719 passes the House of Delegates

    Virginia SB1719 passes the House of Delegates

    Originally posted on the Virginia NORML Blog

    Richmond, Va — Virginia Senator David Marsden’s SB1719 has passed unanimously through both the House of Delegates and the Senate, and is headed to the governor’s desk for signature.

    SB1719 allows “registered agents” for those patients physically unable to pick up or receive delivery of their medical cannabis, like those in hospice, assisted living facilities, and those who rely on home healthcare providers.

    “This law will ensure that patients who may be physically incapable of picking up these life-changing medicines on their own will have access to them from throughout the Commonwealth,” said Senator Marsden, of Fairfax County.

    Virginia NORML members with Senator Dave Marsden

    Virginia NORML members meet with Senator Dave Marsden

    It is patients like Tamara Lyn Netzel, a teacher from Alexandria who suffers from multiple sclerosis, who stand to benefit from this legislation.

    “Multiple sclerosis is a degenerative disease with severe symptoms that come and go, so I’ve accepted at some point I may not be able to drive a car safely or leave my home,” said Netzel. “It is comforting to know I will still be able to send my husband to get the medicine I need.”

    SB1719, which passed unanimously through both the House of Delegates and Virginia Senate, will also allow Virginia’s licensed pharmaceutical processors to transfer products between the five state-authorized facilities, ensuring that patients have access to a wider range of products. It will also prevent the limited availability of products that could result should a provider experience crop failure.

    “Allowing the exchange of various products between licensed processors will create better product selections for patients, depending on their need, regardless of their location in Virginia,” said Senator Marsden. “I am proud to be part of this effort.”

    SB1719 ensures that patients will greater access to the medicines they need, a key element of continuity needed for the success of any health system.

    “Patient access is critical to the success of Virginia’s medical cannabis program,” said Jenn Michelle Pedini, executive director of Virginia NORML. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

    Other medical cannabis-related bills are still making their way through the legislature. Senator Siobhan Dunnavant’s SB1557 expands Virginia’s medical cannabis program, adding nurse practitioners and physician assistants, and allowing a wide range of full therapeutic-strength formulations to be dispensed.

    Delegate Chris L. Hurst’s HB1720 and Senator Glen Sturtevant’s SB1632 would authorize school nurses to administer and registered student patients to use Virginia-approved medical cannabis products at school.

    “We’ve received emails and calls from concerned parents throughout the Commonwealth who are worried their children could be expelled for using their doctor-recommended medical cannabis oil at school,” said Jenn Michelle Pedini, executive director of Virginia NORML. “Delegate Hurst’s and Senator Sturtevant’s bills would provide a much-needed solution for these families.”

    Track this and all marijuana-related legislation on Virginia NORML’s 2019 legislation monitoring page.

  • by Jenn Michelle Pedini, NORML Development Director December 20, 2018

    Del. Chris HurstVirginia State Delegate Chris L. Hurst (D-12) has filed HB 1720 to allow students registered with Virginia’s medical cannabis program to use their medicine at school and school-sponsored activities.

    If passed, the bill would prohibit a school board from suspending or expelling from school attendance a student who possesses or uses Virginia’s allowed medical cannabis oils on school property, on a school bus, or at a school-sponsored activity if they are a registered patient and maintain an unexpired written certification.

    “We’ve received emails and calls from concerned parents throughout the Commonwealth who are worried their children could be expelled for using their doctor-recommended medical cannabis oil at school,” said Jenn Michelle Pedini, executive director of Virginia NORML. “Delegate Hurst’s bill would provide a much-needed solution for these families.”

    The bill does not provide explicit guidance as to how the medicine would be administered on school property.

    Take Action: Click here to send a message to your lawmakers in support of this bill.

    Track this and all marijuana-related legislation on Virginia NORML’s 2019 legislation monitoring page.

  • by Paul Armentano, NORML Deputy Director May 25, 2018

    By a margin of nearly 2 to 1, Oklahoma voters support the passage of State Question 788 — a voter-initiated measure to permit patients access to marijuana for therapeutic purposes. Oklahomans will decide on the measure in a special election on Tuesday, June 26.

    According to polling data compiled by SoonerPoll.com and released today, 58 percent of likely voters endorse the measure, while 30 percent oppose it. Public support for the patient-centric initiative — which empowers physicians to use their discretion when determining cannabis therapy — has largely held steady, even in the face of growing, organized opposition from members of law enforcement and certain business leaders.

    Under the plan, licensed medical marijuana patients may cultivate up to six mature plants, and obtain personal use quantities of marijuana flower, edibles, or infused concentrates from regulated dispensaries. NORML formally endorsed the measure in January.

    Initiative proponents gathered sufficient signatures to place the issue before voters in 2016. However, the vote was postponed because when the state attorney general attempted to reword the initiative’s ballot title in a misleading manner. Initiative proponents sued to restore the title’s original wording. This year, proponents fought back legislation which sought to preemptively amend the initiative in a manner that would have curtailed the rights of both patients and their physicians.

    Voters in three other states — Michigan, Missouri, and Utah — are anticipated to decide on Election Day on statewide marijuana reform initiatives. Recent polling from those states finds majority public support for all three measures.

  • by Paul Armentano, NORML Deputy Director February 22, 2018

    The enactment of statewide laws regulating the use and distribution of cannabis for medical purposes is not associated with increased marijuana use among young people, according to a review of relevant studies published online ahead of print in the journal Addiction.

    Investigators from Columbia University, the RAND Corporation, the University of California at Davis, and the Boston School of Public Health reviewed 11 studies developed from four ongoing national surveys. The studies were published between the years 1991 and 2014. None of the studies identified any significant changes in youth use patterns that could be attributable to changes in marijuana’s legal status.

    Authors concluded: “[A]ll estimates of pre–post changes in past-month marijuana use within MML (medical marijuana law) states from these studies were non-significant. … In summary, current evidence does not support the hypothesis that MML passage is associated with increased marijuana use prevalence among adolescents in states that have passed such laws.”

    One of the study’s senior authors, Dr. Deborah Hasin, further stated in an accompanying press release, “For now, there appears to be no basis for the argument that legalizing medical marijuana has increased teens’ use of the drug.”

    The findings are consistent with those of numerous prior studies, including a federally funded 2015 study published in the journal Lancet Psychiatry that assessed marijuana use patterns of over one-million adolescents in 48 states. That paper concluded, [C]oncerns that increased marijuana use is an unintended effect of state marijuana laws seem unfounded.”

    Separate studies report that teens’ use of marijuana and access to cannabis have declined significantly over the better part of the past two decades – during the same time that the majority of states enacted medical marijuana access programs. Data from states that regulate the adult use and sale of cannabis similarly fail to report any associated uptick in either youth use or marijuana access.

    Text of the study, “Medical marijuana laws and adolescent marijuana use in the United States: A systematic review and meta-analysis,” is not yet available online.

Page 1 of 1212345...10...Last »